SKIN WHEAL - Subcutaneous or Intradermal Lidocaine in Epidural for Laboring Pain.
Prospective, Single-Center, Randomized, Double-Blind, Clinical Trial for The Evaluation of Pain Associated to The Epidural Tuohy Needle Insertion With Prior Administration of Subcutaneous or Intradermal Lidocaine in Parturient Women Requesting Epidural Analgesia for Laboring Pain.
1 other identifier
interventional
51
1 country
1
Brief Summary
The purpose of this study is to explore the differences between the pain associated with epidural Tuohy needle insertion with prior administration of subcutaneous or intradermal lidocaine using two different pain assessment tools (numerical rate scale (NRS) and Critical-Care Pain Observation Tool (CPOT)) in parturient women requesting epidural analgesia for laboring pain. Subjects will go through the following study procedures: review of medical history prior to surgery. Subjects will be randomly assigned to one of the two study groups in a 1:1 ratio to one of the two different standard methods to administer lidocaine prior to epidural Tuohy needle insertion: intradermal or subcutaneous lidocaine administration. Prior to insertion of the Tuohy epidural needle, each patient will receive an injection of 3 mL 1% lidocaine either intradermally (Group Intradermal) or subcutaneously (Group Subcutaneous). A blinded observer (positioned in front of the patient and unable to see the procedure) will record baseline NRS scores, HR, and BP after the patient has been positioned for the epidural procedure and prior to the administration of lidocaine. During the procedure, the blinded observer will objectively record patient's vocal responses, facial expressions, bodily movements, and muscle tension (caused by pain reflex) using the CPOT and NRS scales during lidocaine administration and the first Tuohy needle insertion. After each injection, the blinded observer will record the corresponding heart rate. When the procedural anesthesiologist has exited the room, the blinded observer will then collect the patient's procedure satisfaction score from 0 (worst satisfaction) to 10 (most satisfaction) at the conclusion of the procedure. Likewise, the blinded observer will also collect the final post-procedure heart rate and blood pressure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 13, 2023
CompletedFirst Submitted
Initial submission to the registry
January 12, 2024
CompletedFirst Posted
Study publicly available on registry
February 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2026
CompletedFebruary 25, 2026
February 1, 2026
2.2 years
January 12, 2024
February 23, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
The Critical-Care Pain Observation Tool (CPOT)
To assess the differences in The Critical-Care Pain Observation Tool pain scores (as units) during lidocaine administration and at epidural Tuohy needle insertion between both groups. The Critical-Care Pain Observation Tool (CPOT) includes four behavioral pain indicators (facial expressions, body movements, muscle tension and patient's vocalizations) to assess pain in critical care settings, rating pain levels with a score from 0-8.
Procedure (during lidocaine administration and at epidural Tuohy needle insertion)
Secondary Outcomes (4)
Numerical rating score (NRS) for pain
Procedure (during lidocaine administration and at epidural Tuohy needle insertion)
Blood pressure (BP)
at baseline, Procedure (during lidocaine administration and at epidural Tuohy needle insertion)
Heart Rate (HR)
at baseline, Procedure (during lidocaine administration and at epidural Tuohy needle insertion)
Patient procedural satisfaction score
at 30 minutes after the epidural procedure
Study Arms (2)
INTRADERMAL
ACTIVE COMPARATORPrior to insertion of the Tuohy epidural needle, each patient will receive an injection of 3 mL 1% lidocaine either intradermally (Group Intradermal).
SUBCUTANEOUS
ACTIVE COMPARATORPrior to insertion of the Tuohy epidural needle, each patient will receive an injection of 3 mL 1% lidocaine subcutaneously (Group Subcutaneous).
Interventions
Prior to insertion of the Tuohy epidural needle, each patient will receive an injection of 3 mL 1% lidocaine either intradermally (Group Intradermal) or subcutaneously (Group Subcutaneous).
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years old
- Parturient women requesting epidural analgesia for laboring pain
- Ability to consent in English language
You may not qualify if:
- Women undergoing cesarean delivery.
- Administration of opioids in the 4 hours before study enrollment.
- Administration of IV magnesium sulfate within the last 24 hours.
- Diabetes mellitus (Type I and II).
- Neurocardiogenic signs or symptoms (e.g., dizziness, lightheadedness, bradycardia, and syncope) during IV cannulation.
- Cervical dilation \>6 cm (if in labor).
- BMI ≥ 35.
- Spinal anesthesia.
- Chronic pain patients.
- Opioid use disorder
- Patient with intrauterine fetal demise
- Prisoners.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- A blinded observer (positioned in front of the patient and unable to see the procedure) will record data during the epidural procedure
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 12, 2024
First Posted
February 1, 2024
Study Start
November 13, 2023
Primary Completion
January 31, 2026
Study Completion
January 31, 2026
Last Updated
February 25, 2026
Record last verified: 2026-02